Influenza A Virus, H3N2 Subtype
"Influenza A Virus, H3N2 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.
| Descriptor ID |
D053122
|
| MeSH Number(s) |
B04.820.545.405.400.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Influenza A Virus, H3N2 Subtype".
Below are MeSH descriptors whose meaning is more specific than "Influenza A Virus, H3N2 Subtype".
This graph shows the total number of publications written about "Influenza A Virus, H3N2 Subtype" by people in this website by year, and whether "Influenza A Virus, H3N2 Subtype" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2007 | 4 | 0 | 4 |
| 2008 | 2 | 1 | 3 |
| 2009 | 0 | 3 | 3 |
| 2010 | 2 | 1 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 4 | 5 |
| 2017 | 4 | 1 | 5 |
| 2018 | 2 | 5 | 7 |
| 2019 | 2 | 2 | 4 |
| 2020 | 3 | 5 | 8 |
| 2021 | 0 | 12 | 12 |
| 2022 | 1 | 5 | 6 |
| 2023 | 1 | 5 | 6 |
| 2024 | 3 | 7 | 10 |
| 2025 | 2 | 3 | 5 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza A Virus, H3N2 Subtype" by people in Profiles.
-
Pediatric Vaccine Effectiveness Against Influenza Hospitalization and Outpatient Visits: 2021-2024. Pediatrics. 2026 May 01; 157(5).
-
Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness. Sci Rep. 2024 09 13; 14(1):21466.
-
Gene editing of pigs to control influenza A virus infections. Emerg Microbes Infect. 2024 Dec; 13(1):2387449.
-
Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients. Blood Adv. 2024 04 23; 8(8):1880-1892.
-
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2024 01 25; 78(1):217-226.
-
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clin Infect Dis. 2023 04 17; 76(8):1358-1363.
-
Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020. Clin Infect Dis. 2023 02 08; 76(3):e1031-e1039.
-
Influenza Challenge Models: Ready for Prime Time? Clin Infect Dis. 2020 12 31; 71(11):3012-3013.
-
Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep. 2018 Feb 16; 67(6):180-185.
-
Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018. Pediatrics. 2017 Oct; 140(4).